PROTEIN-KINASE-C INHIBITORS INDUCE APOPTOSIS IN HUMAN-MALIGNANT GLIOMA CELL-LINES

被引:194
|
作者
COULDWELL, WT
HINTON, DR
HE, SK
CHEN, TC
SEBAT, I
WEISS, MH
LAW, RE
机构
[1] UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT MED,DIV ENDOCRINOL DIABET & HYPERTENS,LOS ANGELES,CA 90033
关键词
PROTEIN KINASE C; APOPTOSIS; GLIOMA; STAUROSPORINE; TAMOXIFEN;
D O I
10.1016/0014-5793(94)00415-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous work has demonstrated the importance of the protein kinase C (PKC) system in regulating glioma growth, and has led to clinical trials utilizing PKC inhibitors as adjuncts in the therapy of patients harboring malignant gliomas. This study was performed to explore the possibility that inhibition of PKC in gliomas was triggering an apoptosis signal. Glioma cell lines were treated with PKC inhibitors staurosporine (10 nM), and tamoxifen (10 mu M). DNA from cells treated with each of these drugs exhibited a 'ladder' pattern of oligonucleosome-sized fragments characteristic of apoptosis, thus suggesting that in glioma cells, these drugs may be cytocidal in action.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 50 条
  • [1] INDUCTION OF APOPTOSIS (PROGRAMMED CELL-DEATH) IN HUMAN ESTABLISHED GLIOMA CELL-LINES BY PROTEIN-KINASE-C INHIBITORS
    SABIT, I
    COULDWELL, WT
    HINTON, DR
    HE, S
    WIESS, MH
    LAW, R
    [J]. CLINICAL RESEARCH, 1994, 42 (01): : A54 - A54
  • [2] CHARACTERIZATION OF 4 HUMAN-MALIGNANT GLIOMA CELL-LINES
    STUDER, A
    DISERENS, AC
    GAIDE, AC
    MATTHIEU, JM
    CARREL, S
    STAVROU, D
    DETRIBOLET, N
    [J]. ACTA NEUROPATHOLOGICA, 1985, 66 (03) : 208 - 217
  • [3] INHIBITION OF GROWTH OF ESTABLISHED HUMAN GLIOMA CELL-LINES BY MODULATORS OF THE PROTEIN-KINASE-C SYSTEM
    COULDWELL, WT
    ANTEL, JP
    APUZZO, MLJ
    YONG, VW
    [J]. JOURNAL OF NEUROSURGERY, 1990, 73 (04) : 594 - 600
  • [4] HUMAN-MALIGNANT MELANOMA CELL-LINES
    POPE, JH
    MORRISON, L
    MOSS, DJ
    PARSONS, PG
    MARY, SR
    [J]. PATHOLOGY, 1979, 11 (02) : 191 - 195
  • [5] DIFFERENTIAL SENSITIVITY OF HUMAN CANCER CELL-LINES TO PROTEIN-KINASE-C AGONISTS
    MENENDEZ, AT
    KOZIKOWSKI, A
    DOUGHERTY, M
    KRAMER, R
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 91 - 91
  • [6] ESTABLISHMENT OF HUMAN-MALIGNANT MESOTHELIOMA CELL-LINES
    VERSNEL, MA
    BOUTS, MJ
    HOOGSTEDEN, HC
    VANDERKWAST, TH
    DELAHAYE, M
    HAGEMEIJER, A
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (02) : 256 - 260
  • [7] EXPRESSION OF C-SIS IN HUMAN-MALIGNANT MESOTHELIOMA CELL-LINES
    VERSNEL, MA
    HOOGSTEDON, HC
    BOUTS, MJ
    VANDERKWAST, TH
    HAGEMEIJER, A
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1809 - 1809
  • [8] LACK OF EXPRESSION OF TUMOR-SUPPRESSOR GENES IN HUMAN-MALIGNANT GLIOMA CELL-LINES
    GODBOUT, R
    MIYAKOSHI, J
    DOBLER, KD
    ANDISON, R
    MATSUO, K
    ALLALUNISTURNER, MJ
    TAKEBE, H
    DAY, RS
    [J]. ONCOGENE, 1992, 7 (09) : 1879 - 1884
  • [9] COEXPRESSION OF STEM-CELL FACTOR AND ITS RECEPTOR C-KIT IN HUMAN-MALIGNANT GLIOMA CELL-LINES
    STANULLA, M
    WELTE, K
    HADAM, MR
    PIETSCH, T
    [J]. ACTA NEUROPATHOLOGICA, 1995, 89 (02) : 158 - 165
  • [10] ALTERATIONS IN THE EXPRESSION OF THE PROTEIN-KINASE-C ISOTYPES IN HUMAN CELL-LINES AND TISSUE BIOPSIES
    YAMANISHI, DT
    OHNO, S
    JAKOWATZ, J
    GOODMAN, M
    MEYSKENS, FL
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 95 - 95